NO914056D0 - Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat - Google Patents

Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat

Info

Publication number
NO914056D0
NO914056D0 NO914056A NO914056A NO914056D0 NO 914056 D0 NO914056 D0 NO 914056D0 NO 914056 A NO914056 A NO 914056A NO 914056 A NO914056 A NO 914056A NO 914056 D0 NO914056 D0 NO 914056D0
Authority
NO
Norway
Prior art keywords
preparing
procedure
benzodiazepine derivatives
benzodiazepine
derivatives
Prior art date
Application number
NO914056A
Other languages
English (en)
Other versions
NO914056L (no
Inventor
Ferenc Andrasi
Peter Botka
Katalin Goldschmidt
Tamas Hamori
Gyula Horvath
Jeno Koroesi
Imre Moravcsik
Marta Rusz
Eva Tomori
Gabor Zolyomi
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of NO914056D0 publication Critical patent/NO914056D0/no
Publication of NO914056L publication Critical patent/NO914056L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/02Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO91914056A 1990-10-17 1991-10-16 Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat NO914056L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU906469A HU207055B (en) 1990-10-17 1990-10-17 Process for producing new 5h-2,3-benzodiazepine derivative and pharmaceutical compositions comprising same

Publications (2)

Publication Number Publication Date
NO914056D0 true NO914056D0 (no) 1991-10-16
NO914056L NO914056L (no) 1992-04-21

Family

ID=10971685

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91914056A NO914056L (no) 1990-10-17 1991-10-16 Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat

Country Status (27)

Country Link
US (1) US5204343A (no)
JP (1) JPH04282374A (no)
KR (1) KR920008011A (no)
CN (1) CN1033582C (no)
AT (1) AT399506B (no)
AU (1) AU648111B2 (no)
BE (1) BE1004995A3 (no)
CA (1) CA2053622A1 (no)
CH (1) CH682400A5 (no)
CZ (1) CZ282249B6 (no)
DE (1) DE4134402A1 (no)
DK (1) DK174891A (no)
ES (1) ES2036137B1 (no)
FI (1) FI914918A (no)
FR (1) FR2668148B1 (no)
GB (1) GB2248838B (no)
GR (1) GR1001068B (no)
HU (1) HU207055B (no)
IL (1) IL99637A (no)
IT (1) IT1256279B (no)
NL (1) NL9101741A (no)
NO (1) NO914056L (no)
PL (1) PL167108B1 (no)
RU (1) RU2058982C1 (no)
SE (1) SE506380C2 (no)
YU (1) YU47859B (no)
ZA (1) ZA918273B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9701284A3 (en) * 1997-07-24 2005-11-28 Egyt Gyogyszervegyeszeti Gyar Use of 2,3-benzodiazepine derivatives for producing pharmaceutical compositions for treating and prophylacting illnesses and conditions connected with the endogene opioide system
US6649607B2 (en) * 2001-05-18 2003-11-18 Vela Pharmaceuticals, Inc. Compositions and methods for treating or preventing convulsions or seizures
US7022700B2 (en) * 2002-12-03 2006-04-04 Vela Pharmaceuticals, Inc. Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines
US6864251B2 (en) * 2002-12-03 2005-03-08 Vela Pharmaceuticals, Inc. Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines
MXPA05005895A (es) * 2002-12-03 2006-02-08 Vela Pharmaceuticals Inc Composicion farmaceutica de 1-(3, 4-dimetoxifenil)-4 -metil-5-etil -7-metoxi-8 -hidroxi- 5h-2, 3-benzodiacepina y usos de la misma.
US6638928B1 (en) 2002-12-03 2003-10-28 Vela Pharmaceuticals, Inc. Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines
US20040152695A1 (en) * 2002-12-03 2004-08-05 Vela Pharmaceuticals, Inc. Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3-benzodiazepine and uses thereof
US20040224943A1 (en) * 2003-02-19 2004-11-11 Leventer Steven M. Method of lowering body temperature with (R) - 2,3-benzodiazepines
US20040162284A1 (en) * 2003-02-19 2004-08-19 Harris Herbert W. Method of lowering body temperature with (S) tofisopam
US20040254173A1 (en) * 2003-06-13 2004-12-16 Leventer Steven M. Modulation of dopamine responses with substituted (S)-2,3-benzodiazepines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2257274A1 (en) * 1974-01-16 1975-08-08 Synthelabo Substd. 1,2-diazepin-7-one analgesic and psychotropic agents - prepd by cyclizing a delta keto acid and a substd hydrazine
HU179018B (en) * 1978-10-19 1982-08-28 Gyogyszerkutato Intezet Process for producing new 5h-2,3-benzodiazepine derivatives
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines

Also Published As

Publication number Publication date
GR910100426A (en) 1992-09-25
RU2058982C1 (ru) 1996-04-27
BE1004995A3 (fr) 1993-03-16
AU8592291A (en) 1992-04-30
FI914918A (fi) 1992-04-18
CN1033582C (zh) 1996-12-18
GR1001068B (el) 1993-04-28
JPH04282374A (ja) 1992-10-07
SE9103022L (sv) 1992-04-18
ZA918273B (en) 1994-10-04
YU47859B (sh) 1996-02-19
ITMI912745A1 (it) 1993-04-17
PL292091A1 (en) 1992-06-26
GB2248838B (en) 1994-04-06
HUT59381A (en) 1992-05-28
AT399506B (de) 1995-05-26
CZ282249B6 (cs) 1997-06-11
ATA207191A (de) 1994-10-15
ITMI912745A0 (it) 1991-10-17
FI914918A0 (fi) 1991-10-17
AU648111B2 (en) 1994-04-14
HU906469D0 (en) 1991-04-29
GB2248838A (en) 1992-04-22
IT1256279B (it) 1995-11-29
DK174891A (da) 1992-04-18
PL167108B1 (pl) 1995-07-31
NL9101741A (nl) 1992-05-18
NO914056L (no) 1992-04-21
KR920008011A (ko) 1992-05-27
CS314191A3 (en) 1992-05-13
IL99637A0 (en) 1992-08-18
HU207055B (en) 1993-03-01
DE4134402A1 (de) 1992-05-14
FR2668148A1 (fr) 1992-04-24
SE506380C2 (sv) 1997-12-08
CN1060838A (zh) 1992-05-06
DK174891D0 (da) 1991-10-16
ES2036137B1 (es) 1994-03-01
FR2668148B1 (fr) 1993-07-30
CA2053622A1 (en) 1992-04-18
IL99637A (en) 1996-06-18
ES2036137A1 (es) 1993-05-01
CH682400A5 (de) 1993-09-15
US5204343A (en) 1993-04-20
SE9103022D0 (sv) 1991-10-17
YU166991A (sh) 1994-06-10
GB9122090D0 (en) 1991-11-27

Similar Documents

Publication Publication Date Title
NO913234D0 (no) Fremgangsmaate for fremstilling av pyrazolderivater.
FI923931A (fi) Anordning foer granskning av insidan av en foergrenad roerlinje
DE69119329T2 (de) Actinonin-Derivate
DE69125099D1 (de) Indolderivate
ATE144765T1 (de) Hiv-hemmende benzenacetamidderivate
NO913745D0 (no) Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater
NO914250D0 (no) Fremgangsmaate for fremstilling av piperazinderivater
ATE171449T1 (de) Oxadolderivate
NO922134D0 (no) Fremgangsmaate for fremstilling av glykosyltransferase
NO920965D0 (no) Fremgangsmaate for fremstilling av etylen-alfa-olefinkopolymerer
NO924028L (no) Forbedret fremgangsmaate for fremstilling av substituerte indolonderivater
NO901070L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO914504L (no) Fremgangsmaate for fremstilling av dietere
NO914056D0 (no) Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat
NO171910C (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler
NO914053D0 (no) Fremgangsmaate for fremstilling av 8-klorokinolonderivater
NO901071D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO893713L (no) Fremgangsmaate for fremstilling av benzoksazolon-derivater.
NO912980D0 (no) Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenderivater
NO925007D0 (no) Fremgangsmaate for fremstilling av benzofuranylimidazolderivater
NO914985D0 (no) Fremgangsmaate for fremstilling av 15-nitro-tabersonin-derivater
NO911672L (no) Fremgangsmaate for fremstilling av alkansulfonanilid-derivater.
NO172095C (no) Framgangsmaate for framstilling av sondenaering
NO914452L (no) Fremgangsmaate for fremstilling av isokinolinderivater
NO923481D0 (no) Fremgangsmaate for fremstilling av 1-hydroksyalkyl-5-nitroimidazol